Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis

Mostrar otras versiones (1)

Current therapies for multiple sclerosis (MS) are largely palliative, not curative. Mesenchymal stem cells (MSCs) harbor regenerative and immunosuppressive functions, indicating a potential therapy for MS, yet the variability and low potency of MSCs from adult sources hinder their therapeutic potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaofang, Kimbrel, Erin A., Ijichi, Kumiko, Paul, Debayon, Lazorchak, Adam S., Chu, Jianlin, Kouris, Nicholas A., Yavanian, Gregory J., Lu, Shi-Jiang, Pachter, Joel S., Crocker, Stephen J., Lanza, Robert, Xu, Ren-He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110787/
https://www.ncbi.nlm.nih.gov/pubmed/25068126
http://dx.doi.org/10.1016/j.stemcr.2014.04.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110787/
https://www.ncbi.nlm.nih.gov/pubmed/25068126
http://dx.doi.org/10.1016/j.stemcr.2014.04.020

Ejemplares similares